M&A speculation rife in pharma
If 2003 was marked by consolidation in the biotechnology industry, then in 2004 the spotlight seems to have tracked firmly back to pharmaceuticals - and particularly the European majors.
Archives for January 22, 2004
Elan raises €55m in new sell-off
Irish pharmaceutical group Elan has raised around $70 million (€55m) from four new deals, including the sale of formulation and manufacturing interests.
Food poisoning bug aids vaccine research
The bacterium Listeria monocytogenes is well known as a cause of food poisoning, but could also improve the safety and effectiveness of vaccines for a number of viral diseases, according to US researchers.
Gentle microplate washing
Bio-Tek Instruments has launched a new microplate washer designed to have a gentler action to avoid interfering with the results of cell-based assays.
Amersham, GE merger on track for April
General Electric's €8.1 billion acquisition of the UK's Amersham was approved by the European Union yesterday, after it concluded that the deal would not create a monopoly in Europe's medical imaging market.
New enzymes for chiral alcohols
BioCatalytics has expanded its product line of enzymes for chemical synthesis with the addition of new ketoreductases (KRED) enzymes for the stereoselective reduction of ketones.